Anzeige
Mehr »
Login
Samstag, 21.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News: Vorweihnachtlicher Kaufrausch an der Börse?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
291 Leser
Artikel bewerten:
(1)

Piperidine Market worth $86 million by 2027 - Exclusive Report by MarketsandMarkets

Finanznachrichten News

CHICAGO, June 9, 2022 /PRNewswire/ -- According to the new market research report "Piperidine Market by Type (99% Purity and 98% Purity), End Use Industry (Pharmaceutical, Agrochemicals, Rubber, and Others), Region (Asia Pacific, Europe, North America, Middle East & Africa and South America) - Global Forecast to 2027", published by MarketsandMarkets, the global Piperidine Market is projected to grow from USD 64 million in 2022 to USD 86 million by 2027, at a CAGR of 5.9% from 2022 to 2027. The market growth is fuelled by the growing demand of pharmaceutical drug in treatment of chronic disease and drug for aging-related, high demand as solvents, base and catalyst in different industries.

MarketsandMarkets Logo

Browse in-depth TOC on "Piperidine Market"

191 - Tables
44 - Figures
172- Pages

View Detailed Table of Content Here: https://www.marketsandmarkets.com/Market-Reports/piperidine-market-262881406.html

99% purity segment to dominate the piperidine market in terms of value during the forecast period

BY type segment include 99% purity and 98% purity subsegments. 99% purity type is projected to dominate the market and to grow at faster rate than 98% purity type. This is due to the need of high purity APIs in pharmaceutical industry to ensure quality of drug. In addition, demand of pharmaceutical drugs are increasing pertaining to the rise in prevalence of diseases. This is fueling the demand for 99% purity piperidine.

Pharmaceutical end use industry segment to dominate the piperidine market during the forecast period

By end use industry segment includes pharmaceutical, agrochemicals, rubber, and others subsegment. Pharmaceutical end use industry is projected to dominate the piperidine market with larges market share. This is attributed to the growing affordability of healthcare treatments, increasing diseases prevalence, improved governmental policies for approval and launch of pharmaceutical drugs.

Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=262881406

Europe is the second-largest market for piperidine market during the forecast period

Europe is projected to be the second-largest market for piperidine globally. The major markets in Europe, such as Germany, France, Italy, Russia, Spain, and the UK, have a high demand for piperidine. This is due to the presence of leading crop protection chemical manufacturers and API manufacturers in the region. Factors such as the increasing prevalence of chronic diseases, rising government investments in the pharmaceutical sector, and the growing pharmaceutical industry are driving the European piperidine market.

The piperidine market comprises major solution providers, are BASF SE (Germany), Koei Chemical Co. Ltd. (Japan), Vertellus (US), Jubilant Ingrevia Limited (India), Vasudha Pharma (India), Taj Pharmaceuticals Ltd. (India), Avantor Inc. (US), Allchem Lifescience Pvt. Ltd. (India), Toronto Research Chemicals (Canada), Merck KGaA (Germany) among others. The study includes an in-depth competitive analysis of these key players in the piperidine market, with their company profiles, and key market strategies.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=262881406

Browse Adjacent Markets: Specialty Chemicals Market Research Reports & Consulting

Related Reports:

Pyridine & Pyridine Derivatives Market by Type (Pyridine, Beta Picoline, Alpha Picoline, Gamma Picoline), Application (Agrochemicals, Pharmaceuticals, Latexes, Food), Region (North America, Europe, Asia Pacific) - Global Forecast to 2021

https://www.marketsandmarkets.com/Market-Reports/pyridine-derivatives-market-36411434.html

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/piperidine-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/piperidine.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

© 2022 PR Newswire
6 Richtige für 2025
Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.